To blunt threats from price-driven competitors, W2O and Stallergenes Greer (STAGR) partnered to create a digital ecosystem that would cement the company’s status as the allergy immunotherapy provider with the best value-added service and education. Our primary goals were to provide high-touch experiences that delivered on true customer educational needs and that closely mirrored the experiences customers were accustomed to in their one-on-one, personal interactions with STAGR service representatives, scientists and field force team members.
Founded by Jim Weiss in 2001 and built on an ethos of entrepreneurship, staying fluid and doing the right thing, W2O has achieved 18 years of uninterrupted growth while remaining fiercely independent. W2O is an alchemic mix of 1,400 people and hundreds of clients and partners – working from bench to bedside – to make the world a healthier place. Driven by data, W2O applies proprietary analytics and best-in-class technology to build insights that power creative ideas and concepts. W2O seeks to become the partner of choice to empower optimal healthcare knowledge, access and outcomes.